Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121869694 | 12186969 | 4 | F | 20160312 | 20160628 | 20160317 | 20160706 | EXP | PHEH2016US006154 | NOVARTIS | 48.55 | YR | M | Y | 90.70000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121869694 | 12186969 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 22527 | .5 | MG | CAPSULE | QD | ||||||
| 121869694 | 12186969 | 2 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | 1000 IU, QD | U | 0 | 1000 | IU | QD | ||||||
| 121869694 | 12186969 | 3 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | 250 MG, QD | U | 0 | 250 | MG | QD | ||||||
| 121869694 | 12186969 | 4 | C | CREATINE | CREATINE | 1 | Unknown | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 121869694 | 12186969 | 5 | C | NIACINAMIDE | NIACINAMIDE | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 121869694 | 12186969 | 6 | C | JUICE PLUS | DIETARY SUPPLEMENT | 1 | Unknown | UNK UNK, QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121869694 | 12186969 | 1 | Multiple sclerosis |
| 121869694 | 12186969 | 2 | Product used for unknown indication |
| 121869694 | 12186969 | 3 | Product used for unknown indication |
| 121869694 | 12186969 | 4 | Product used for unknown indication |
| 121869694 | 12186969 | 5 | Product used for unknown indication |
| 121869694 | 12186969 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121869694 | 12186969 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121869694 | 12186969 | Abdominal discomfort | |
| 121869694 | 12186969 | Asthenia | |
| 121869694 | 12186969 | Blood pressure decreased | |
| 121869694 | 12186969 | Electrocardiogram QT prolonged | |
| 121869694 | 12186969 | Headache | |
| 121869694 | 12186969 | Heart rate decreased | |
| 121869694 | 12186969 | Hepatic enzyme increased | |
| 121869694 | 12186969 | Hypoaesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121869694 | 12186969 | 1 | 20160312 | 0 |